The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, W.
Right arrow Articles by Schwartz, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, W.
Right arrow Articles by Schwartz, L. B.
The Journal of Immunology, 2005, 175: 2635-2642.
Copyright © 2005 by The American Association of Immunologists

Cytokine Production by Skin-Derived Mast Cells: Endogenous Proteases Are Responsible for Degradation of Cytokines 1

Wei Zhao*, Carole A. Oskeritzian2,{dagger}, Andrea L. Pozez{ddagger} and Lawrence B. Schwartz3,{dagger}

* Department of Pediatrics, {dagger} Department of Internal Medicine, and {ddagger} Department of Surgery, Virginia Commonwealth University, Richmond, VA 23298

The current study characterizes the cytokine protein (ELISA) and mRNA (gene array and RT-PCR) profiles of skin-derived mast cells cultured under serum-free conditions when activated by cross-linking of Fc{epsilon}RI. Prior to mast cell activation, mRNA only for TNF-{alpha} was detected, while after activation mRNA for IL-5, IL-6, IL-13, TNF-{alpha}, and GM-CSF substantially increased, and for IL-4 it minimally increased. However, at the protein level certain recombinant cytokines, as measured by ELISAs, were degraded by proteases released by these skin-derived mast cells. IL-6 and IL-13 were most susceptible, followed by IL-5 and TNF-{alpha}; GM-CSF was completely resistant. These observations also held for the endogenous cytokines produced by activated mast cells. By using protease inhibitors, chymase and cathepsin G, not tryptase, were identified in the mast cell releasates as the likely culprits that digest these cytokines. Their cytokine-degrading capabilities were confirmed with purified chymase and cathepsin G. Soy bean trypsin inhibitor, when added to mast cell releasates, prevented the degradation of exogenously added cytokines and, when added to mast cells prior to their activation, prevented degradation of susceptible endogenous cytokines without affecting either degranulation or GM-CSF production. Consequently, substantial levels of IL-5, IL-6, IL-13, TNF-{alpha}, and GM-CSF were detected 24–48 h after mast cells had been activated, while none were detected 15 min after activation, by which time preformed granule mediators had been released. IL-4 was not detected at any time point. Thus, unless cytokines are protected from degradation by endogenous proteases, cytokine production by human mast cells with chymase and cathepsin G cells may be grossly underestimated.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Kato, R. T. Chustz, T. Ogasawara, M. Kulka, H. Saito, R. P. Schleimer, and K. Matsumoto
Dexamethasone and FK506 Inhibit Expression of Distinct Subsets of Chemokines in Human Mast Cells
J. Immunol., June 1, 2009; 182(11): 7233 - 7243.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Zhao, G. Gomez, S.-H. Yu, J. J. Ryan, and L. B. Schwartz
TGF-{beta}1 Attenuates Mediator Release and De Novo Kit Expression by Human Skin Mast Cells through a Smad-Dependent Pathway
J. Immunol., November 15, 2008; 181(10): 7263 - 7272.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. E. Sutherland, J. S. Olsen, A. McKinstry, S. A. Villalta, and P. J. Wolters
Mast Cell IL-6 Improves Survival from Klebsiella Pneumonia and Sepsis by Enhancing Neutrophil Killing
J. Immunol., October 15, 2008; 181(8): 5598 - 5605.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Tiwari, C.-C. Wang, C. Brochetta, G. Ke, F. Vita, Z. Qi, J. Rivera, M. R. Soranzo, G. Zabucchi, W. Hong, et al.
VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways
Blood, April 1, 2008; 111(7): 3665 - 3674.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Gomez, S. Jogie-Brahim, M. Shima, and L. B. Schwartz
Omalizumab Reverses the Phenotypic and Functional Effects of IgE-Enhanced Fc{epsilon}RI on Human Skin Mast Cells
J. Immunol., July 15, 2007; 179(2): 1353 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.
Physiol Rev, October 1, 2006; 86(4): 1309 - 1379.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
W. Zhao, C. L. Kepley, P. A. Morel, L. M. Okumoto, Y. Fukuoka, and L. B. Schwartz
Fc{gamma}RIIa, Not Fc{gamma}RIIb, Is Constitutively and Functionally Expressed on Skin-Derived Human Mast Cells
J. Immunol., July 1, 2006; 177(1): 694 - 701.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
Q.-Y. Zhang, J.-B. Ge, J.-Z. Chen, J.-H. Zhu, L.-H. Zhang, C.-P. Lau, and H.-F. Tse
Mast Cell Contributes to Cardiomyocyte Apoptosis after Coronary Microembolization
J. Histochem. Cytochem., May 1, 2006; 54(5): 515 - 523.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.